Skip to content

Clinical trials

Completed Schizophrenia Spectrum and Other Psychotic Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Spectrum and Other Psychotic Disorders Status: Completed Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20041
20051
20063
20093
20102
20121
20132
20142
20154
20163
20175
20183
20194
20204
20214
20227

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre for Addiction and Mental Health4
University of Minnesota3
AbbVie2
Chinese University of Hong Kong2
Fundación Marques de Valdecilla2
National Institute on Drug Abuse (NIDA)2
Yale University2
Agiad Psychiatry Hospital1
Behman Hospital1
Brown University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia Spectrum and Other Psychotic Disorders52
Schizophrenia30
Psychotic Disorders26
Mental Disorders14
Mood Disorders6
Affective Disorders, Psychotic5
Bipolar Disorder3
Personality Disorders3
Tobacco Use Disorder3
Metabolic Syndrome2

Trials

Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.